A new method for producing biologically active nanocomplexes by a noncovalent conjugation of proteins with viral particles

[1]  T. Nandedkar.  Nanovaccines: recent developments in vaccination , 2009, Journal of Biosciences.

[2]  A. Efimov,et al.  Domain organization of the N-terminal portion of hordeivirus movement protein TGBp1. , 2009, The Journal of general virology.

[3]  Byung O. Lee,et al.  Use of hepadnavirus core proteins as vaccine platforms , 2009, Expert review of vaccines.

[4]  David J Evans.  Exploitation of plant and archaeal viruses in bionanotechnology. , 2009, Biochemical Society transactions.

[5]  M. Ozkan,et al.  Hybrid assembly of CPMV viruses and surface characteristics of different mutants. , 2009, Current topics in microbiology and immunology.

[6]  N. Steinmetz,et al.  Structure-based engineering of an icosahedral virus for nanomedicine and nanotechnology. , 2009, Current topics in microbiology and immunology.

[7]  David E Cliffel,et al.  Nanoparticle-based biologic mimetics. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[8]  G. Boivin,et al.  Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. , 2008, Vaccine.

[9]  K. Palmer,et al.  Genetically engineered Tobacco mosaic virus as nanoparticle vaccines , 2008, Expert review of vaccines.

[10]  L. Nemchinov,et al.  Transient expression of the ectodomain of matrix protein 2 (M2e) of avian influenza A virus in plants. , 2007, Protein expression and purification.

[11]  K. Palmer,et al.  Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protection. , 2006, Bioconjugate chemistry.

[12]  John E. Johnson,et al.  A cowpea mosaic virus nanoscaffold for multiplexed antibody conjugation: application as an immunoassay tracer. , 2006, Biosensors & bioelectronics.

[13]  R. Twyman,et al.  The Potential of Plant Virus Vectors for Vaccine Production , 2006, Drugs in R&D.

[14]  G. Lomonossoff,et al.  Development of cowpea mosaic virus-based vectors for the production of vaccines in plants , 2005, Expert review of vaccines.

[15]  John E. Johnson,et al.  Chemical conjugation of heterologous proteins on the surface of Cowpea mosaic virus. , 2004, Bioconjugate chemistry.

[16]  A. Jackson,et al.  The Role of Metabolites in Bioequivalency Assessment. I. Linear Pharmacokinetics without First-Pass Effect , 2004, Pharmaceutical Research.

[17]  M. Young,et al.  Chemical modification of a viral cage for multivalent presentation. , 2002, Chemical communications.

[18]  John E. Johnson,et al.  Icosahedral virus particles as addressable nanoscale building blocks. , 2002, Angewandte Chemie.

[19]  H. Koprowski,et al.  The green revolution: plants as heterologous expression vectors. , 2001, Vaccine.

[20]  W. Hamilton,et al.  Cowpea mosaic virus as a vaccine carrier of heterologous antigens , 2001, Molecular biotechnology.

[21]  R. Beachy,et al.  Display of epitopes on the surface of tobacco mosaic virus: impact of charge and isoelectric point of the epitope on virus-host interactions1 , 1999, Journal of Molecular Biology.

[22]  Y. Okada,et al.  Systemic production of foreign peptides on the particle surface of tobacco mosaic virus , 1995, FEBS letters.